176 related articles for article (PubMed ID: 8083095)
21. Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Shiau AC; Yu CY; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
J Radiat Res; 2010; 51(2):173-9. PubMed ID: 20339254
[TBL] [Abstract][Full Text] [Related]
22. High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women.
Fujikawa K; Miyamoto T; Ihara Y; Matsui Y; Takeuchi H
Gynecol Oncol; 2001 Jan; 80(1):21-3. PubMed ID: 11136564
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change.
Rodrigus P; De Winter K; Venselaar JL; Leers WH
Radiother Oncol; 1997 Feb; 42(2):137-41. PubMed ID: 9106922
[TBL] [Abstract][Full Text] [Related]
25. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
[TBL] [Abstract][Full Text] [Related]
26. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
[TBL] [Abstract][Full Text] [Related]
27. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328
[TBL] [Abstract][Full Text] [Related]
28. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
[TBL] [Abstract][Full Text] [Related]
29. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
Logsdon MD; Eifel PJ
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation.
Perez CA; Grigsby PW; Lockett MA; Chao KS; Williamson J
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):855-66. PubMed ID: 10386643
[TBL] [Abstract][Full Text] [Related]
31. Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
Manea E; Escande A; Bockel S; Khettab M; Dumas I; Lazarescu I; Fumagalli I; Morice P; Deutsch E; Haie-Meder C; Chargari C
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):411-420. PubMed ID: 29559282
[TBL] [Abstract][Full Text] [Related]
32. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
Fokdal L; Pötter R; Kirchheiner K; Lindegaard JC; Jensen NBK; Kirisits C; Chargari C; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K
Radiother Oncol; 2018 Jun; 127(3):423-430. PubMed ID: 29784450
[TBL] [Abstract][Full Text] [Related]
33. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer.
Eifel PJ; Jhingran A; Bodurka DC; Levenback C; Thames H
J Clin Oncol; 2002 Sep; 20(17):3651-7. PubMed ID: 12202666
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications.
Perez CA; Breaux S; Bedwinek JM; Madoc-Jones H; Camel HM; Purdy JA; Walz BJ
Cancer; 1984 Jul; 54(2):235-46. PubMed ID: 6722748
[TBL] [Abstract][Full Text] [Related]
35. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of rectal and bladder complications after RALS therapy for carcinoma of the uterine cervix].
Teshima T; Chatani M; Hata K; Inoue T; Suzuki T
Gan No Rinsho; 1984 Nov; 30(14):1793-800. PubMed ID: 6513032
[TBL] [Abstract][Full Text] [Related]
37. A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy.
Kim TH; Kim JY; Sohn DK; Kim YJ; Lee YS; Moon SH; Kim SS; Kim DY
Radiat Oncol; 2013 Jan; 8():28. PubMed ID: 23369265
[TBL] [Abstract][Full Text] [Related]
38. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy in locally advanced cancer of the cervix.
Biswal BM; Rath GK; Joshi RC; Mohanti BK; Ganesh T; Singh R
Med J Malaysia; 1998 Mar; 53(1):30-6. PubMed ID: 10968134
[TBL] [Abstract][Full Text] [Related]
40. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
